Sinorhiozbium bacteriophage HMSP1-Susan has a genome of 51,963 bp in size, with a GC content of 52.5%. It contains 97 putative coding sequences; 83% of these coding sequences (CDS) encode proteins classified as hypothetical or having unknown functions. HMSP1 has limited homology to previously reported viruses and likely represents a new phage that infects this nitrogen-fixing bacterium.
Staphylococcus aureus is one of the main bacteria that affect human health. Its reduced susceptibility to beta-lactam antibiotics has driven the clinical use of macrolides and lincosamides. However, the presence of macrolide-lincosamide-streptogramin B (MLSB)-resistant S. aureus strains is increasingly common. Wastewater treatment plants (WWTPs) are the main anthropogenic source of resistance determinants. However, few studies have assessed the importance of this environment on the dissemination of MLSB-resistant S. aureus strains. Thus, we aimed to evaluate the impact of a domestic WWTP on the resistance to MLSB and penicillin in S. aureus in southeast Brazil. Of the 35 isolates tested, 40.6% were resistant to penicillin. Resistance to erythromycin (8.6%) and quinolones (2.8%) was less common. Despite the low rate of resistance to clindamycin (2.8%), many isolates showed reduced susceptibility to this antibiotic (57.1%). Regarding the resistance phenotypes of staphylococci isolates, inducible MLSB resistance (D-test positive) was found in two isolates. In addition, 27 S. aureus isolates showed the ability to produce penicillinase. In this article, we report for the first time the importance of WWTPs in the dissemination of MSLB resistance among S. aureus from southeast Brazil.
Aminoglycosides are broad‐spectrum antibiotics common in clinical, veterinary, and agricultural settings and are often reserved for treating severe bacterial infections. With antibiotic resistance becoming a global crisis, understanding the mechanisms by which bacteria attain such resistance is more urgent than ever. One such mechanism specific to aminoglycosides is ribosomal modification by methyltransferases (RMTases). RMTases pose a significant threat as they grant simultaneous resistance to various aminoglycosides and are transmitted between species. The purpose of this project was to develop a 3D physical model of NpmA, an RMTase that confers blanket resistance to aminoglycoside antibiotics by transferring a methyl group to the A1408 nucleotide in helix 44 of the 30S ribosomal subunit. Methylation of A1408 makes helix 44 unrecognizable to these antibiotics. Database searches and sequence alignments were performed to identify conserved amino acids and structural features important in the catalytic mechanism of NpmA. Details of the protein structure and its interaction with helix 44 were obtained by analyzing the Protein Databank File 4OX9. To construct the physical model, the structure file (4OX9) was imported into Jmol and modified into a format suitable for 3D printing using scripts created by undergraduate researchers. The 3D model features NpmA interacting with rRNA and S‐adenosyl‐L‐methionine, the methyl group donor for the methylation reaction. The physical model also highlights key amino acids such as Arg207, E146, Trp107 and Trp197, which are critical to flip A1408 from helix 44 and position it into the enzyme's active site prior to methylation. A Jmol tutorial was created to complement the 3D model and assess students' learning of the structure and function of NpmA. Initial assessment of this activity showed improvement of students' protein visualization abilities, and computational skills. Future work will focus on field‐testing the complete exercise in a microbiology course to evaluate the impact of the 3D model on students' understanding of the mechanisms of antimicrobial resistance.Support or Funding InformationThis project was supported by NSF‐DUE 1725940 awarded to the CREST (Connecting Researchers, Educators, and Students) ProjectThis abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.